Current methods of pharmacologic stress testing and the potential advantages of new agents.

Current methods of pharmacologic stress testing and the potential advantages of new agents.

Item
http://www.wikidata.org/entity/Q37405704
The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.Identification of left ventricular myocardial ischemia and cardiac prognosis with cardiovascular magnetic resonance: updates from 2008 to 2010.Adenosine signaling pathways as potential therapeutic targets in respiratory disease.Fractional flow reserve in acute coronary syndromes: A review.SPECT and PET in ischemic heart failure.Prognosis of a normal positron emission tomography 82Rb myocardial perfusion imaging study in women with no history of coronary disease.Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis.Does risk for major adverse cardiac events in patients undergoing vasodilator stress with adjunctive exercise differ from patients undergoing either standard exercise or vasodilator stress with myocardial perfusion imaging?Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging.Use of regadenoson for measurement of fractional flow reserve.CT myocardial perfusion imaging: ready for prime time?
P2860

Current methods of pharmacologic stress testing and the potential advantages of new agents.

Item
http://www.wikidata.org/entity/Q37405704
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current methods of pharmacolog ...... tial advantages of new agents.
@en
Current methods of pharmacolog ...... tial advantages of new agents.
@nl
type
label
Current methods of pharmacolog ...... tial advantages of new agents.
@en
Current methods of pharmacolog ...... tial advantages of new agents.
@nl
prefLabel
Current methods of pharmacolog ...... tial advantages of new agents.
@en
Current methods of pharmacolog ...... tial advantages of new agents.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Current methods of pharmacolog ...... tial advantages of new agents.
@en
P2093
P304
P31
P356
P433
P478
P577
P5875
P698
P921